Alnylam Pharmaceuticals | ALNY - EPS Earnings Per Share

Stock Price
330.34
Daily Change
11.49 3.60%
Monthly
2.09%
Yearly
41.81%
Q2 Forecast
309.25

Alnylam Pharmaceuticals reported $1.25 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.99 -0.01 Apr/30
FY2025Q4 Dec/2025 1.25 1.27 0.06 Feb/12
FY2025Q3 Sep/2025 2.90 0.27 -0.50 Oct/30
FY2025Q2 Jun/2025 0.32 -0.73 0.56 Jul/31
FY2025Q1 Mar/2025 -0.01 -0.94 -0.16 May/01




Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 1.54 0.48 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR -0.67 3.62 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Takeda JPY 65.74 73.57 Dec/2025
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025
Xencor USD -0.09 0.01 Dec/2025